Article

GFPT2 controls immune evasion in EGFR-mutated non-small cell lung cancer

2024-04-26

Abstract excerpt

<title>Abstract</title> <p>In the evolving field of cancer immunotherapy, EGFR-mutated non-small cell lung cancer (NSCLC) poses a significant obstacle due to its inherent resistance to conventional treatments. The development of an effective strategy to overcome this resistance remains a challenge. Here we have identified glutamine fructose-6-phosphate transaminase 2 (GFPT2) as a prime architect in the immune eva...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 65848010-b5f7-5b7b-a471-961ea6f72fac
DOI: 10.21203/rs.3.rs-4203208/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GFPT2 controls immune evasion in EGFR-mutated non-small cell lung cancerDOI 10.21203/rs.3.rs-4203208/v1Read

Targeting GFPT2 to reinvigorate immunotherapy in EGFR-mutated NSCLCSemantic proximity Read

Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 ( GFPT2 ) is a prognostic marker in gastric cancerSemantic proximity Read

Downregulation of GFPT2 enhances cisplatin chemotherapy sensitivity in STK11/KRAS mutant non-small cell lung cancer by regulating the hexosamine biosynthesis pathway, resisting tumor growth.Semantic proximity Read

SLC2A1 promotes chemo-immunotherapy resistance in lung adenocarcinoma by modulating the AKT signaling pathwaySemantic proximity Read

Roles of GFPT2 Expression Levels On the Prognosis and Tumor Microenvironment of Colon CancerSemantic proximity Read

Exosome-like biogenesis from the Golgi releases extracellular vesicles lacking conventional tetraspanins that mediate immune evasion in cancerSemantic proximity Read

Integrated proteomic and glycoproteomic analysis reveals heterogeneity and molecular signatures of brain metastases from lung adenocarcinomas.Semantic proximity Read

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.Semantic proximity Read

TGM2-TUFM promotes acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC through p62-mediated lipophagy.Semantic proximity Read

Glut10 is a Novel Immune Regulator Involved in Lung Cancer Immune Cell Infiltration and Predicts Worse Survival When Transcriptionally Down-RegulatedSemantic proximity Read

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.Semantic proximity Read

Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon CancerSemantic proximity Read